Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended December 2024,…
26,790$
0,04%
Echtzeit-Aktienkurs Collegium Pharmaceutical Inc.
Bid:
Ask:
Nachrichten zur Collegium Pharmaceutical Inc. Aktie
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 14.94% and 0.86%, respectively, for the quarter ended December 2024. Do…
Collegium Pharmaceutical beats Q4 estimates, shares rise 6.3% By Investing.com
Collegium Pharmaceutical beats Q4 estimates, shares rise 6.3%…
Collegium Pharmaceutical stock hits 52-week low at $28.75 By Investing.com
Collegium Pharmaceutical stock hits 52-week low at $28.75…
Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion
…
Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript
…
Collegium Pharmaceutical: Making Steady Progress
…
Collegium Pharmaceutical: Diversifying And Growing
…
Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript
…
Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
Collegium Pharmaceutical (COLL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
Collegium Pharmaceutical: Some Positives From Its Quarterly Miss
…
Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript
…
Collegium Pharmaceutical to redeem outstanding 2.625% convertible senior notes due 2026
…
Collegium Pharmaceutical Q4: The Beat Goes On
…